US2013338372A1PendingUtilityA1

Substituted Imidazoline Compounds

49
Assignee: TEPE JETZEPriority: Oct 9, 2007Filed: Jun 26, 2012Published: Dec 19, 2013
Est. expiryOct 9, 2027(~1.2 yrs left)· nominal 20-yr term from priority
Inventors:Jetze J. TepeJames Marino Hamby
C07D 233/28
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to compositions comprising substituted imidazoline compounds including prodrugs, and salts thereof. In some embodiments, the invention relates to the use of these compositions as therapeutic agents, preferably for the treatment of arthritis or cancer. In further embodiments, The invention relates to the pharmaceutical compositions with effective amounts of substituted imidazoline compounds disclosed herein that function as agonist or antagonists of the genetic expression or interactions with transcription factor NF-κB.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A compound having the following formula:

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.